AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Apremilast in South Africa
10 products registered with SAHPRA — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| APREMILAST 10 mg GLENMARK | 54/13.9.1/0567.564 | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | 14 Feb 2028 |
| APTIKA 10 mg | 54/13.9.1/0564 | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | 14 Feb 2028 |
| APTIKA 20 mg | 54/13.9.1/0565 | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | 14 Feb 2028 |
| APREMILAST 30 mg GLENMARK | 54/13.9.1/0569.566 | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | 14 Feb 2028 |
| APREMILAST 20 mg GLENMARK | 54/13.9.1/0568.565 | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | 14 Feb 2028 |
| APTIKA 30 mg | 54/13.9.1/0566 | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | 14 Feb 2028 |
| OTEZLA 10 mg | 51/32/0864 | Amgen South Africa (Pty)Ltd | suspended | 9 Jul 2025 |
| OTEZLA 30 mg | 51/32/0866 | Amgen South Africa (Pty)Ltd | suspended | 9 Jul 2025 |
| OTEZLA 20 mg | 51/32/0865 | Amgen South Africa (Pty)Ltd | suspended | 9 Jul 2025 |
| OTEZLA Starter Pack | 56/32/0041 | Amgen South Africa (Pty)Ltd | suspended | 9 Jul 2025 |
Apremilast — SAHPRA Registration Details
SAHPRA (South Africa) has 10 registered products containing Apremilast, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Apremilast registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.